RhG-CSF對(duì)MMTV-erbB2轉(zhuǎn)基因鼠乳腺發(fā)育的影響
本文選題:重組人粒細(xì)胞集落刺激因子 切入點(diǎn):MCF-10A 出處:《河南科技大學(xué)》2015年碩士論文
【摘要】:目的:1.研究重組人粒細(xì)胞集落刺激因子(Rh G-CSF)對(duì)人類正常乳腺細(xì)胞株MCF-10A和乳腺癌細(xì)胞株SK-BR-3增殖作用的影響。2.探討Rh G-CSF對(duì)乳腺癌模型MMTV-erb B2轉(zhuǎn)基因鼠乳腺發(fā)育的影響。方法:1.體外培養(yǎng)人正常乳腺上皮細(xì)胞株MCF-10A和乳腺癌細(xì)胞株SKBR-3細(xì)胞株,將含不同濃度的Rh G-CSF的培養(yǎng)液與MCF-10A和SK-BR-3共同培養(yǎng)不同時(shí)間,然后利用MTT法,研究Rh G-CSF對(duì)人乳腺正常細(xì)胞MCF-10A和乳腺癌細(xì)胞株SK-BR-3增殖率的影響。2.選擇鼠齡12周的健康雌性MMTV-er Bb2轉(zhuǎn)基因鼠60只,隨機(jī)分為三組,分別為低劑量組:Rh G-CSF藥物小鼠皮下注射(劑量為0.125μg,每日一次);高劑量組:Rh G-CSF藥物小鼠皮下注射(劑量為0.25μg,每日一次);對(duì)照組:生理鹽水小鼠皮下注射(劑量為0.25μg,每日一次)。Rh G-CSF藥物皮下注射8周后,每組取6只小鼠解剖,取小鼠腹部左下側(cè)完整乳腺組織行Whole mount染色,觀察小鼠乳腺大體形態(tài)結(jié)構(gòu)的變化,然后應(yīng)用HE染色法觀察小鼠乳腺導(dǎo)管結(jié)構(gòu)發(fā)育情況,用免疫組織化學(xué)染色SP法檢測(cè)各組小鼠乳腺組織內(nèi)PCNA蛋白表達(dá)情況,用實(shí)時(shí)定量PCR(Real Time-PCR)法,檢測(cè)cyclin D1、c-myc、VEGF、G-CSF3R在各組小鼠乳腺組織中的表達(dá)。結(jié)果:1.經(jīng)不同濃度的Rh G-CSF藥物處理細(xì)胞后,高低劑量的Rh G-CSF藥物對(duì)人類正常乳腺細(xì)胞MCF-10A的增殖作用均不明顯,而與對(duì)照組相比,乳腺癌細(xì)胞株SK-BR-3在低劑量時(shí)細(xì)胞增殖作用明顯。2.Whole mount結(jié)果顯示,用藥8周后,小鼠乳腺形態(tài)以對(duì)照組為參考,低劑量組乳腺小葉發(fā)育旺盛,小鼠乳腺導(dǎo)管數(shù)目增多(P=0.000),而高劑量組小鼠乳腺導(dǎo)管增殖民作用不明顯(P=0.027)。3.各組小鼠乳腺組織內(nèi)增殖細(xì)胞核抗原(Proliferating Cell Nuclear Antigen PCNA)與對(duì)照組相比,低劑量組PCNA高表達(dá)(P=0.000),高劑量組PCNA陽(yáng)性不明顯(P=0.004),Real Time-PCR結(jié)果顯示細(xì)胞增殖基因和相關(guān)通路因子如cyclin D1、c-myc、VEGF、G-CSF3R的m RNA表達(dá)水平在乳腺組織中與對(duì)照組相比,低劑量時(shí)高表達(dá),高劑量時(shí)作用不明顯(P0.05)。結(jié)論:1.Rh G-CSF對(duì)人類正常乳腺細(xì)胞MCF-10A的增殖作用不明顯,對(duì)乳腺癌細(xì)胞株SK-BR-3低劑量時(shí)具有增殖作用。2.Rh G-CSF對(duì)MMTV-erb B2轉(zhuǎn)基因鼠乳腺發(fā)育具有影響,在低劑量明顯促進(jìn)小鼠乳腺發(fā)育,而高劑量時(shí)乳腺發(fā)育增殖作用不明顯。
[Abstract]:Objective 1. To study the effects of recombinant human granulocyte colony stimulating factor (Rh G-CSF) on the proliferation of human breast cancer cell line MCF-10A and breast cancer cell line SK-BR-3. 2. To investigate the effect of Rh G-CSF on breast development in breast cancer model MMTV-erb B2 transgenic mice. Methods 1. Human breast epithelial cell line MCF-10A and breast cancer cell line SKBR-3 cell line were cultured in vitro. The culture medium containing different concentrations of Rh G-CSF was co-cultured with MCF-10A and SK-BR-3 for different time, and then MTT method was used. To study the effect of Rh G-CSF on the proliferation rate of human breast normal cell MCF-10A and breast cancer cell line SK-BR-3. 2. Sixty healthy female MMTV-er Bb2 transgenic mice of 12 weeks of age were selected and randomly divided into three groups. Low dose group (0.125 渭 g, once a day); high dose group (0.25 渭 g, once a day); control group: normal saline mice subcutaneously (0.25 渭 g). Rh G-CSF was injected subcutaneously once a day for 8 weeks. Six mice in each group were dissected, and the intact breast tissues of the left and lower abdomen of the mice were stained with Whole mount to observe the changes of the gross morphology of the mammary glands of the mice, and then to observe the development of the ductal structure of the mammary glands of the mice by HE staining. Immunohistochemical staining SP method was used to detect the expression of PCNA protein in the mammary gland of mice in each group, and real-time quantitative PCR(Real Time-PCR method was used to detect the expression of cyclin D1c-mycfon G-CSF3R in the mammary gland of mice in each group. Results: 1. After the cells were treated with different concentrations of Rh G-CSF, the expression of GCSF3R in mammary gland of each group was detected. The effects of Rh G-CSF at high and low doses on the proliferation of MCF-10A in human normal breast cells were not obvious. However, compared with the control group, the proliferation of breast cancer cell line SK-BR-3 was obvious at low dose. 2. Whole mount showed that, after 8 weeks of treatment, the proliferation of breast cancer cell line SK-BR-3 was significantly higher than that of control group. The mammary gland morphology of mice was referred to the control group, and the development of mammary lobule in low dose group was strong. The number of mammary ducts increased in mice, but the proliferative effect of mammary ducts in high dose group was not obvious. The proliferating Cell Nuclear Antigen PCNA (proliferating Cell Nuclear Antigen PCNA) in mammary gland of mice in each group was higher than that in control group. In the low dose group, the expression of PCNA was higher than that in the control group, and the expression of m RNA in the high dose group was higher than that in the control group. The results showed that the expression of proliferative gene and related pathway factors such as cyclin D1 c-myct G-CSF3R in the breast tissue was higher than that in the control group, and the expression of m RNA in the high dose group was higher than that in the control group. Conclusion: 1. Rh G-CSF has no obvious effect on the proliferation of MCF-10A in human normal breast cells, but it has a proliferative effect on breast cancer cell line SK-BR-3 at low dose. 2. Rh G-CSF has an effect on mammary gland development of MMTV-erb B2 transgenic mice. The development of mammary gland in mice was obviously promoted at low dose, but the proliferation of mammary gland was not obvious at high dose.
【學(xué)位授予單位】:河南科技大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2015
【分類號(hào)】:R737.9
【共引文獻(xiàn)】
相關(guān)期刊論文 前10條
1 蔡長(zhǎng)景;劉持;秦曉群;;巨噬細(xì)胞參與腎纖維化的分子機(jī)制及治療研究進(jìn)展[J];廣東醫(yī)學(xué);2014年05期
2 胡磐;冉雪琴;王嘉福;;柯樂豬血液基因組甲基化修飾與細(xì)胞因子水平的相關(guān)性[J];貴州農(nóng)業(yè)科學(xué);2015年04期
3 楊陽(yáng);羅萍;;非造血組織中EPO/EPOR作用的研究進(jìn)展[J];成都醫(yī)學(xué)院學(xué)報(bào);2015年03期
4 文玲波;楊蘭平;;癌性貧血的中西醫(yī)治療進(jìn)展[J];大家健康(學(xué)術(shù)版);2013年20期
5 付長(zhǎng)江;劉蘇;郭立新;閆世偉;左相榮;李瑞冰;;JAK-STAT通路在兔心肌缺血后處理中的作用[J];臨床薈萃;2014年12期
6 邱瑞芬;王遠(yuǎn)紅;高群;李帥;呂志華;;仿刺參糖胺聚糖對(duì)骨髓抑制貧血小鼠外周血及骨髓細(xì)胞周期的影響[J];中國(guó)海洋藥物;2015年01期
7 ;燮G;張占強(qiáng);魏美玲;馬寧;趙亮;王海;;丁苯酞對(duì)腦梗死后相關(guān)炎性因子的影響研究進(jìn)展[J];中國(guó)實(shí)用神經(jīng)疾病雜志;2015年09期
8 張軍峰;史利利;張力;李紅波;張建水;祁存芳;劉勇;徐曦;;HRE介導(dǎo)的NT-3表達(dá)上調(diào)減輕大鼠局灶性腦缺血再灌注損傷[J];基礎(chǔ)醫(yī)學(xué)與臨床;2015年09期
9 鄭旭銳;樊英華;韋永紅;宋健;曹寧;王禮鳳;應(yīng)小平;惠毅;;姜黃素對(duì)肝星狀細(xì)胞JAK2-STAT3信號(hào)通路的影響[J];陜西中醫(yī);2013年09期
10 劉慶山;陳小玉;莊述娟;;基因表達(dá)譜芯片技術(shù)進(jìn)展及其在中藥網(wǎng)絡(luò)藥理學(xué)研究中的應(yīng)用[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2014年02期
相關(guān)會(huì)議論文 前2條
1 范勝軍;李學(xué)軍;;Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles[A];第十一屆全國(guó)博士生學(xué)術(shù)年會(huì)(生物醫(yī)藥專題)論文集(中冊(cè),墻報(bào)P1-P24)[C];2013年
2 李瀟;賈玫;侯麗;祁爍;陳信義;;復(fù)方阿膠漿對(duì)胃腸道腫瘤化療相關(guān)性貧血患者血清EPO濃度水平影響的臨床觀察[A];中華中醫(yī)藥學(xué)會(huì)第二屆岐黃論壇——血液病中醫(yī)藥防治分論壇論文集[C];2014年
相關(guān)博士學(xué)位論文 前10條
1 柳昀熠;吉馬酮對(duì)肝癌細(xì)胞的抑制作用及其機(jī)理研究[D];華中科技大學(xué);2013年
2 王蓓;EV71拮抗I型干擾素產(chǎn)生的分子機(jī)制研究[D];北京協(xié)和醫(yī)學(xué)院;2013年
3 賀理宇;IL-4/STAT6、HIPK2對(duì)IgA腎病人腭扁桃體低糖基化IgA1表達(dá)的調(diào)控機(jī)制研究[D];中南大學(xué);2013年
4 余少杰;基于P物質(zhì)和降鈣素基因相關(guān)肽的神經(jīng)免疫調(diào)節(jié)對(duì)小鼠同種異體皮膚移植物存活影響的研究[D];中南大學(xué);2013年
5 張玉超;生長(zhǎng)激素與其信號(hào)轉(zhuǎn)導(dǎo)分子STAT5B對(duì)脂肪細(xì)胞的影響及其與胰島素信號(hào)的Crosstalk[D];山東大學(xué);2013年
6 李政;瘦素在人腰椎間盤髓核退變中的作用及機(jī)制研究[D];北京協(xié)和醫(yī)學(xué)院;2013年
7 李轉(zhuǎn)見;奶山羊泌乳相關(guān)miRNA鑒定及miR-2478調(diào)控機(jī)制解析[D];西北農(nóng)林科技大學(xué);2013年
8 張耀;基于膽堿能抗炎通路的艾灸治療實(shí)驗(yàn)性RA作用機(jī)制研究[D];成都中醫(yī)藥大學(xué);2013年
9 何建新;HIES疾病中STAT3突變體的功能研究[D];蘭州大學(xué);2013年
10 南晶;TPCA-1作為STAT3與NF-κB信號(hào)的雙重抑制劑對(duì)肺癌抗腫瘤作用機(jī)制的研究[D];蘭州大學(xué);2014年
相關(guān)碩士學(xué)位論文 前10條
1 陳明;骨髓單個(gè)核細(xì)胞在腦缺血大鼠腦內(nèi)受損區(qū)域的定向分化[D];鄭州大學(xué);2013年
2 周恒;STAT3分子的磷酸化及其調(diào)控機(jī)制在電針預(yù)處理腦保護(hù)效應(yīng)中的研究[D];第四軍醫(yī)大學(xué);2013年
3 謝tq;人參皂苷Rd對(duì)腦缺血后NMDA受體磷酸化的影響及機(jī)制研究[D];第四軍醫(yī)大學(xué);2013年
4 相娜娜;促紅細(xì)胞生成素治療化療所致腫瘤相關(guān)性貧血的系統(tǒng)評(píng)價(jià)[D];新疆醫(yī)科大學(xué);2013年
5 趙鴻雁;腦梗死與2-型糖尿病患者血清G-CSF水平的研究[D];石河子大學(xué);2013年
6 魏強(qiáng);人參皂苷Rg1調(diào)控白血病細(xì)胞增殖分化和存活的EpoR機(jī)制研究[D];重慶醫(yī)科大學(xué);2013年
7 曹雪;骨髓干細(xì)胞動(dòng)員對(duì)腦梗死患者外周血MCV、RDW-CV及相關(guān)參數(shù)水平的影響及臨床意義[D];大連醫(yī)科大學(xué);2013年
8 溫平;重組人粒細(xì)胞集落刺激因子對(duì)大鼠腦缺血再灌注損傷腦組織p-JNK、p-ERK表達(dá)及細(xì)胞凋亡的影響[D];山西醫(yī)科大學(xué);2013年
9 邱冬妮;鼻咽癌治療期間血紅蛋白濃度變化對(duì)局部控制的影響[D];廣西醫(yī)科大學(xué);2014年
10 肖廣正;rhG-CSF動(dòng)員骨髓干細(xì)胞及歸巢修復(fù)急性缺血性腦梗死的實(shí)驗(yàn)研究[D];承德醫(yī)學(xué)院;2011年
,本文編號(hào):1687718
本文鏈接:http://sikaile.net/yixuelunwen/zlx/1687718.html